Navigation Links
Hemostatic HemCon Dressings Selected by the Premier Healthcare Alliance for Hemostasis Products Contract
Date:8/18/2009

HemCon Medical Technologies, Inc. today announced that the hemostatic HemCon Patch™ and HemCon® Bandage were the only two products added to the Hemostasis Products category with Premier Purchasing Partners L.P., the group purchasing unit of Premier Inc. The contract is effective August 1, 2009 through Oct 1, 2011. The agreement makes HemCon dressings available at pre-negotiated terms to all 2,100 Premier hospital members through HemCon's exclusive distribution partner, Cardinal Health.

Portland, OR (Vocus) August 18, 2009 -- HemCon Medical Technologies, Inc. today announced that the hemostatic HemCon Patch™ and HemCon® Bandage were the only two products added to the Hemostasis Products category with Premier Purchasing Partners L.P., the group purchasing unit of Premier Inc. The contract is effective August 1, 2009 through Oct 1, 2011. The agreement makes HemCon dressings available at pre-negotiated terms to all 2,100 Premier hospital members through HemCon's exclusive distribution partner, Cardinal Health.

Through this new contract, Premier members will now have access to special pricing for HemCon dressings, which are intended to improve patient care following diagnostic and interventional vascular access procedures. The dressings offer safe and fast hemostasis with an effective antibacterial barrier against a wide spectrum of microorganisms including MRSA, VRE and Acinetobacter baumannii that may help to reduce the risk of hospital acquired infections.

"HemCon is pleased to be included as a contracted supplier for Premier. Our company is committed to creating new healthcare products that drive improved patient safety and better clinical results. We're excited that Premier will make our revolutionary hemostatic products available to their members," said HemCon Chief Executive Officer, John W. Morgan.

The hemostatic HemCon Patch, designed for vascular closure following diagnostic and interventional cardiac catheterization procedures, was highlighted as the only such device to be selected for Premier's inaugural Innovation Celebration. The event celebrated advances in healthcare and highlighted industry leaders committed to innovation and improving care.

About Premier Inc., 2006 Malcolm Baldrige National Quality Award recipient
The Premier healthcare alliance is more than 2,100 U.S. hospitals and 58,000-plus other healthcare sites working together to improve healthcare quality and affordability. Premier maintains the nation's most comprehensive repository of clinical, financial and outcomes information and operates a leading healthcare purchasing network. A world leader in helping deliver measurable improvements in care, Premier works with the Centers for Medicare & Medicaid Services and the United Kingdom's National Health Service North West to improve hospital performance. Premier has offices in San Diego, Charlotte, N.C., Philadelphia and Washington.

About HemCon Medical Technologies, Inc.
HemCon Medical Technologies, Inc. is a leading global developer of advanced medical products designed to improve the standard of patient care. The company is responsible for developing the chitosan-based HemCon dressing used by thousands of military and civilian first responders and is changing wound care best practices in hospital, dental and clinical settings. In addition, HemCon is leading the charge to develop and license unique, life-saving medical advances including lyophilized human plasma and nanofiber technologies for wound care. HemCon is headquartered in Portland, Ore., with additional commercial operations in Ireland, England, Germany and the Czech Republic. For more information, please visit www.hemcon.com.

Media Contact:   
Nicole Elovitz
HemCon Medical Technologies, Inc.
971-223-4918

###

Read the full story at http://www.prweb.com/releases/HemCon/Patch/prweb2763714.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. CryoLife Receives CE Mark Approval for BioFoam(R) Hemostatic Technology
2. Next-Generation Hemostatic Dressing Available for Military Emergencies
3. Next-Generation Hemostatic Dressing Available for Military Emergencies
4. Department of Defense Awards CryoLife $1.7 million to Develop BioFoam Hemostatic Technology
5. Latest Generation of Products From Z-Medica - Hemostatic Gauze - Yields New At-Home Nosebleed Treatment
6. New HemCon/Seal-On Nasal Plugs Control Nosebleeds Quickly, Effectively and Comfortably
7. ConvaTec and HemCon Announce Co-Promotion Agreement
8. Derma Sciences Announces First Commercial Sales of BIOGUARD(TM) Barrier Dressings
9. ConvaTec Announces Expanded Indications for AQUACEL(R) and AQUACEL(R) Ag Dressings in Management of Surgical Wounds
10. AUDIO from Medialink and the Association for Dressings and Sauces: Pass The Mayo! Myths Dispelled During Septembers National Food Safety Education Month
11. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming WUWHS Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hemostatic HemCon Dressings Selected by the Premier Healthcare Alliance for Hemostasis Products Contract
(Date:2/21/2017)... ... February 21, 2017 , ... ... clinical trial solutions, today announced the further expansion of its eHealth App ... can leverage as part of Bioclinica’s extensive and growing eHealth platform. Applications ...
(Date:2/21/2017)... ... February 21, 2017 , ... ... participants. The connected care demonstration spanned multiple health information systems including OpenEMR, ... 30% of providers have no Health Information Exchange outside of faxing. Medal’s innovative ...
(Date:2/21/2017)... , ... February 21, 2017 , ... ... house-caliber protein espresso drinks, announced its products are now available for purchase on ... Protein Drink Mix has become popular among health-conscious consumers who love coffee but ...
(Date:2/20/2017)... ... ... MRI screening improves early diagnosis of breast cancer in all women–not only ... journal Radiology . , MRI has long been known as an effective ... reserve breast MRI screening for women who have a strong family history or other ...
(Date:2/20/2017)... , ... February 20, 2017 , ... Silverado today is ... to open and operate a state-of-the-art memory care community in Alexandria, Virginia. The new ... a site just outside of Old Town. , The three-story community with underground ...
Breaking Medicine News(10 mins):
(Date:2/21/2017)... (NYSE: IBM ) Research has today announced new research ... eye,s retina. The Melbourne based IBM ... abnormalities in retina images, which could in the future offer ... patients who may be at risk of eye diseases – ... developed world. The research began in 2015 ...
(Date:2/21/2017)... NEW YORK , Feb. 21, 2017 /PRNewswire/ ... Read the full report: http://www.reportlinker.com/p04711311-summary/view-report.html ... from COPD and other respiratory diseases. Patients having ... prescribed to use oxygen concentrators. Oxygen concentrators are ... be purchased over the counter. Medical oxygen concentrators ...
(Date:2/21/2017)... 2017   BeyondSpring Pharmaceuticals , a clinical ... innovative immuno-oncology cancer therapies, today announced that the ... Phase 2 trial of BeyondSpring,s innovative lead asset, ... cell lung cancer (NSCLC) with Docetaxel has been ... Clinical Immuno-Oncology Symposium in Orlando, Fla. ...
Breaking Medicine Technology: